Antibiotice Ia (ATB)

Currency in RON
2.1350
-0.0050(-0.23%)
Closed·
ATB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.12002.1450
52 wk Range
1.75202.6400
Key Statistics
Bid/Ask
0.548 / 0.558
Prev. Close
2.25
Open
2.125
Day's Range
2.12-2.145
52 wk Range
1.752-2.64
Volume
73.6K
Average Volume (3m)
142.92K
1-Year Change
-15.2778%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.0000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.0000

Earnings

Latest Release
May 27, 2026
EPS / Forecast
0.02 / --
Revenue / Forecast
142.84M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.05%
Dividend Yield
0.93%
Industry Median 0.25%
Annualized payout
0.02
Paid annually
5-Years Growth
+61.01%
Growth Streak

ATB Income Statement

Compare ATB to Peers and Sector

Metrics to compare
ATB
Peers
Sector
Relationship
P/E Ratio
45.2x16.2x−0.4x
PEG Ratio
−0.670.090.00
Price/Book
1.5x1.1x2.6x
Price / LTM Sales
2.2x1.1x3.1x
Upside (Analyst Target)
24.3%34.4%47.8%
Fair Value Upside
Unlock10.2%6.2%Unlock

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company provides generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for disinfecting surfaces and hands; and veterinary medicines. Its products are available in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, pessaries, and suppositories. It offers active pharmaceutical ingredients. The company exports its products to approximately 70 countries. Antibiotice S.A. was founded in 1955 and is headquartered in Iasi, Romania.

Employees
1355
Market
Romania

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.66M0.69%9.96M
Other Institutional Investors
443.40M66.05%948.88M
Public Companies & Retail Investors
223.28M33.26%477.82M
Total
671.34M100.00%1.44B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ministerul Sanatatii53.02%355,925,135761,680
Infinity Capital Investments S.A.13.03%87,475,826187,198

FAQ

What Is the Antibiotice Ia (ATB) Stock Price Today?

The Antibiotice Ia stock price today is 2.1350 RON.

What Stock Exchange Does Antibiotice Ia Trade On?

Antibiotice Ia is listed and trades on the Bucharest Stock Exchange.

What Is the Stock Symbol for Antibiotice Ia?

The stock symbol for Antibiotice Ia is "ATB."

Does Antibiotice Ia Pay Dividends? What’s The Current Dividend Yield?

The Antibiotice Ia dividend yield is 0.93%.

What Is the Antibiotice Ia Market Cap?

As of today, Antibiotice Ia market cap is 1.4400B RON.

What Is Antibiotice Ia's Earnings Per Share (TTM)?

The Antibiotice Ia EPS (TTM) is 0.0472.

When Is the Next Antibiotice Ia Earnings Date?

Antibiotice Ia will release its next earnings report on Aug 17, 2026.

From a Technical Analysis Perspective, Is ATB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Antibiotice Ia Stock Split?

Antibiotice Ia has split 9 times.

How Many Employees Does Antibiotice Ia Have?

Antibiotice Ia has 1355 employees.

What is the current trading status of Antibiotice Ia (ATB)?

As of Aug 15, 2026, Antibiotice Ia (ATB) is trading at a price of 2.1350 RON, with a previous close of 2.2500 RON. The stock has fluctuated within a day range of 2.1200 RON to 2.1450 RON, while its 52-week range spans from 1.7520 RON to 2.6400 RON.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.